drugset / Trial / NCT06379958
Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects
RandomizedParallel-groupOpen-labelOther
Summary
A DDI study consisting of 4 parts conducted as an open label, fixed sequence study in healthy adult subjects.
Timeline
- Start
- 2024-04-08
- Primary completion
- 2024-09-30
- Completion
- 2024-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Itraconazole | Small molecule | 200 mg | Oral |
| Comparator | Leramistat | Small molecule | 40 mg | Oral |
| Comparator | Phenytoin | Unknown | 100 mg | Oral |
| Comparator | Simvastatin | Small molecule | 40 mg | Oral |
| Comparator | Upadacitinib | Small molecule | 15 mg | Oral |
Indications
No indication recorded.